Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samantha Damude

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
The Journal of Surgical Research|July 15, 2014
A review of animal models for portal vein embolizationFloor Huisman, Krijn P van Lienden, Samantha Damude, et al.
Biotechniques|September 25, 2020
Double venipuncture is not required for adequate S-100B determination in melanoma patientsSamantha Damude, Anneke C Muller Kobold, Esther Bastiaannet, et al.
Clinical Chemistry and Laboratory Medicine|February 5, 2016
Adipocytes in venipunctures cause falsely elevated S-100B serum valuesSamantha Damude, Maarten G Niebling, Anneke C Muller Kobold, et al.
Annals of Surgical Oncology|May 20, 2016
The MELFO-Study: Prospective, Randomized, Clinical Trial for the Evaluation of a Stage-adjusted Reduced Follow-up Schedule in Cutaneous Melanoma Patients-Results after 1 YearSamantha Damude, Josette E H M Hoekstra-Weebers, Anne Brecht Francken, et al.
Annals of Surgical Oncology|September 20, 2019
The MELFO Study: A Multicenter, Prospective, Randomized Clinical Trial on the Effects of a Reduced Stage-Adjusted Follow-Up Schedule on Cutaneous Melanoma IB-IIC Patients-Results After 3 YearsEric A Deckers, Josette E H M Hoekstra-Weebers, Samantha Damude, et al.
Annals of Surgery|July 22, 2022
Follow-up Schedule for Patients With Sentinel Node-negative Cutaneous Melanoma (The MELFO Study): An International Phase III Randomized Clinical TrialMarc D Moncrieff, Esther Bastiaannet, Beverly Underwood, et al.
Journal of Surgical Oncology|August 31, 2019
S-100B as an extra selection tool for FDG PET/CT scanning in follow-up of AJCC stage III melanoma patientsEric A Deckers, Kevin P Wevers, Anneke C Muller Kobold, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
The Journal of Surgical Research|July 15, 2014
A review of animal models for portal vein embolizationFloor Huisman, Krijn P van Lienden, Samantha Damude, et al.
Biotechniques|September 25, 2020
Double venipuncture is not required for adequate S-100B determination in melanoma patientsSamantha Damude, Anneke C Muller Kobold, Esther Bastiaannet, et al.
Clinical Chemistry and Laboratory Medicine|February 5, 2016
Adipocytes in venipunctures cause falsely elevated S-100B serum valuesSamantha Damude, Maarten G Niebling, Anneke C Muller Kobold, et al.
Annals of Surgical Oncology|May 20, 2016
The MELFO-Study: Prospective, Randomized, Clinical Trial for the Evaluation of a Stage-adjusted Reduced Follow-up Schedule in Cutaneous Melanoma Patients-Results after 1 YearSamantha Damude, Josette E H M Hoekstra-Weebers, Anne Brecht Francken, et al.
Annals of Surgical Oncology|September 20, 2019
The MELFO Study: A Multicenter, Prospective, Randomized Clinical Trial on the Effects of a Reduced Stage-Adjusted Follow-Up Schedule on Cutaneous Melanoma IB-IIC Patients-Results After 3 YearsEric A Deckers, Josette E H M Hoekstra-Weebers, Samantha Damude, et al.
Annals of Surgery|July 22, 2022
Follow-up Schedule for Patients With Sentinel Node-negative Cutaneous Melanoma (The MELFO Study): An International Phase III Randomized Clinical TrialMarc D Moncrieff, Esther Bastiaannet, Beverly Underwood, et al.
Journal of Surgical Oncology|August 31, 2019
S-100B as an extra selection tool for FDG PET/CT scanning in follow-up of AJCC stage III melanoma patientsEric A Deckers, Kevin P Wevers, Anneke C Muller Kobold, et al.
Pageof 1